FIELD: medicine.
SUBSTANCE: invention concerns medicine, and can be used for water analysis for biological activity. That is ensured by preparing standard saline of water. Dead-end preparations of nervous cells are prepared and place cells in the saline for preset time. The cells are electrically stimulated by single square-wave pulses of duration 0.1 msec, superthreshold intensity at frequency 1 pulse per hour. Then the excitatory postsynaptic potentials are discharged and recorded both initial and each 2 hours within and after water reaction in cells from a receptor of a-amino-3-hydroxy-5-methylyoxizole-4-propionic acid (AMPA) of the first reciprocal total activating potential of compact neuron group, from a receptor of N-methyl-D-aspartate - the AMPA following reciprocal making active potential of compact neuron group and inhibitory postsynaptic neuron potentials. The biological activity of water in preset time intervals is determined by functioning of nervous cells depending on prolonged water reaction in comparing parametres of nervous cell activity both initial, and within reaction and thereafter.
EFFECT: possibility to compare biological activity of water at molecular-cell level through determining its reaction with dead-end nervous cells.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF WATER ANALYSIS FOR BIOLOGICAL ACTIVITY | 2008 |
|
RU2377563C1 |
METHOD OF IN VITRO SIMULATING AND STUDYING DIABETES CONSEQUENCES | 2009 |
|
RU2427040C1 |
METHOD OF WATER ANALYSIS FOR BIOLOGICAL ACTIVITY | 2008 |
|
RU2377562C1 |
METHOD OF MODELLING AND EXAMINATION OF CONSEQUENCES OF HEMORRHAGIC STROKE IN VITRO | 2007 |
|
RU2340951C1 |
METHOD OF SIMULATION AND EXAMINATION OF HEMORRHAGIC STROKE CONSEQUENCES | 2007 |
|
RU2361283C1 |
METHOD OF SIMULATION AND RESEARCH OF CONSEQUENCES OF HEMORRHAGIC STROKE | 2005 |
|
RU2307396C2 |
ESTIMATE METHOD FOR PROTEIN ACTION ON BRAIN TISSUE | 2007 |
|
RU2359337C2 |
METHOD OF INVESTIGATION OF PROPERTIES OF HEAT SHOCK PROTEIN (HSP70) | 2007 |
|
RU2334988C1 |
PEPTIDE ANTAGONIST OF THE NMDA RECEPTOR | 2019 |
|
RU2716258C1 |
AGENT FOR PROPHYLAXIS, SUPPORTING AND RECOVERING THERAPY FOR CONTROL OF PATHOLOGY DEVELOPING AT AGEING AND/OR PATHOGENIC FACTORS EFFECT ASSOCIATED WITH DYSTROPHIC AND DEGENERATIVE ORGAN AND TISSUE ALTERATIONS | 1995 |
|
RU2083210C1 |
Authors
Dates
2010-01-20—Published
2008-06-09—Filed